In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Bayer and Schering-Plough in marketing alliance

Executive Summary

As part of its corporate restructuring, Bayer AG has licensed Schering-Plough exclusive US and Puerto Rican marketing and distribution rights to all the primary care pharma products of its US subsidiary Bayer HealthCare. In turn, S-P has licensed Bayer Japanese co-promotion rights to its cholesterol absorption inhibitor Zetia (ezetimibe), which is currently under review for CV disorders (if approved, Bayer Yakuhin will market it).
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Product or Technology Swap
    • Marketing-Licensing
    • Co-Promotion

Related Companies

Advertisement
UsernamePublicRestriction

Register